Neuro-Immune Modulation of Cholinergic Signaling in an Addiction Vulnerability Trait.

eNeuro · 2023 · PMC9997697 · PMID 36810148

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

failed to reach significancep = 0.056so close (0.05 < p ≤ 0.1)

4 a ), a two-way ANOVA on the effects of phenotype and treatment indicated significant main effects of phenotype ( F (1,33) = 12.72, p = 0.0011) and treatment ( F (2,33) = 8.16, p = 0.0013), while the interaction between these two factors failed to reach significance ( F (2,33) = 3.16, p = 0.056).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.